Characteristics and quality of life of patients with stage 5 chronic kidney disease admitted to a hospital
DOI:
https://doi.org/10.56511/JIPBS.2018.v5.i03.pp58-61Abstract
Background: Chronic Kidney Disease (CKD) is a global health problem with high morbidity, mortality and therapeutic costs. Patients with CKD have various complications that affect their Quality of Life (QoL). The aim of this study was to determine the QoL of stage 5 CKD patients undergoing hemodialysis treated with erythropoietin in Haji Adam Malik (HAM) Hospital Medan. Methods: A prospective cohort study was conducted to analyze QoL of stage 5 CKD patients with BPJS insurance claims undergoing hemodialysis (n = 88) admitted to HAM Hospital Medan period August to October 2017. The patient’s characteristics were descriptively analyzed. Their QoL was analyzed using SF-36 instrument with 9 dimensions (physical function, physical limitations, emotional, energy, well-being, social function, pain, perception of general health, and health changes). All data were organized in Microsoft Excel and SPSS version 16. The relationship between their QoL, diagnosis, and comorbidities was analyzed by Chi- square. The patient’s QoL scores (in %) were categorized: very good ≥80; good 75- <80; fair 60- <75, poor <60. Results: Most (59%) of the patients were male. The patient’s age was 48.74 ± 14.06 (years). There was a relationship between the QoL of the patients with diagnosis and comorbidities (p = 0.039). The average QoL of the patients (in %) was 47.01 ± 18.41. Most (71.7%) of the patients had poor QoL. Conclusion: Quality of Life of the patients was classified as poor category.
Keywords:
CKD, QoL, SF36Downloads
References
World kidney day. Assessed online 3 rd September 2018 from: www.worldkidneyday.org/faqs/chronic-kidney disease/.
O'Mara NB. Anemia in patients with chronic kidney disease. Diabetes Spectrum 2008; 21(1):12-9. patients based on the diagnosis group . stage 5 CKD patients Good Fair Poor QoL % QoL % QoL 0 0 0 4.5 36.07 0 1.1 60 7 36.89 0 5.7 66.6 14 33.35 79.25 8 67.89 10.2 38.02 75.69 5.7 71.35 36 38.36 20.4 71.7
Cruz MC, Andrade C, Urrutia M, Draibe S, Nogueira-Martins LA, Sesso RD. Quality of life in patients with chronic kidney disease. Clinics 2011; 66(6):991-5.
Merkus MP, Jager KJ, Dekker FW, Boeschoten EW, Stevens P, Krediet RT. Quality of life in patients on chronic dialysis: self-assessment 3 months after the start of treatment. American journal of kidney diseases 1997; 29(4):584-92.
Perlman RL, Finkelstein FO, Liu L, Roys E, Kiser M, Eisele G, BurrowsHudson S, Messana JM, Levin N, Rajagopalan S, Port FK. Quality of life in chronic kidney disease (CKD): a cross-sectional analysis in the Renal Research Institute-CKD study. American journal of kidney diseases 2005; 45(4):658-66.
Abdel-Kader K, Unruh ML, Weisbord SD. Symptom burden, depression, and quality of life in chronic and end-stage kidney disease. Clinical Journal of the American Society of Nephrology 2009; 4(6):1057-64.
Ware Jr JE, Gandek B. Overview of the SF-36 health survey and the international quality of life assessment (IQOLA) project. Journal of clinical epidemiology 1998; 51(11):903-12.
Published
How to Cite
Issue
Section
Copyright (c) 2018 Salmah Handayani Lubis, Azizah Nasution, Khairunnisa

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.


Journal of Innovations in Pharmaceutical and Biological Sciences is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License. Based on a work at